Drug profile · INN
intravenous
intravenous is an FDA-listed pharmaceutical active ingredient.
Drug details — intravenous
- Class
- —
- Route
- —
- Patents
- 18
- Programs
- 129
- Data quality
- 0.70
Quick answer
intravenous is an FDA-listed pharmaceutical active ingredient.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Related patents
-
US 12371333
Purification of clinoptilolite
granted -
US 12343350
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)
granted -
US 2025002606
Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVA
granted -
US 2023302008
METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE
granted -
US 11629060
Purification of clinoptilolite
granted -
US 11596610
Compositions in support of health and mental accuity
granted -
US 11583540
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)
granted -
US 11197869
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)
granted -
SG 11202104918P
THERAPY FOR TREATING CANCER WITH AN INTRATUMORAL AND/OR INTRAVENOUS ADMINISTRATION OF A RECOMBINANT MVA ENCODING 4-1BBL (CD137L) AND/OR CD40L
granted -
US 10117937
Highly branched alpha-D-glucans
granted -
US 10010534
Intravenous formulation and LC/MS/MS analysis method for GMC1
granted -
US 9675572
Intravenous omega-3 fatty acid compositions and method of use
granted -
US 6770283
DNA expression systems based on alphaviruses
expired -
US 6692750
Alphavirus expression vector
expired -
US 6566093
Alphavirus cDNA vectors
expired -
US 6224879
Alphavirus expression vector
expired -
US 6190666
DNA expression systems based on alphaviruses
expired -
US 6013122
Tattoo inks
expired
Frequently asked questions
What is intravenous?
intravenous is an FDA-listed pharmaceutical active ingredient.